Drug Search Results
More Filters [+]

Felbamate

Alternative Names: felbamate, felbatol, felbamat, taloxa
Latest Update: 2024-12-16
Latest Update Note: News Article

Product Description

Mechanisms of Action: GLUN2A Antagonist,GLUN2C Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Austria | Belgium | Chile | Colombia | Egypt | France | Germany | Greece | Hungary | Ireland | Italy | Luxembourg | Netherlands | Norway | Peru | Portugal | Sweden | Switzerland | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Felbamate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events